MML Investors Services’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,741
| Closed | -$203K | – | 2214 |
|
|
2022
Q3 | $203K | Sell |
7,741
-222
| -3% | -$5.82K | ﹤0.01% | 1936 |
|
|
2022
Q2 | $202K | Buy |
7,963
+210
| +3% | +$5.33K | ﹤0.01% | 1911 |
|
|
2022
Q1 | $245K | Sell |
7,753
-5,221
| -40% | -$165K | ﹤0.01% | 1842 |
|
|
2021
Q4 | $525K | Sell |
12,974
-2,097
| -14% | -$84.9K | ﹤0.01% | 1385 |
|
|
2021
Q3 | $526K | Sell |
15,071
-6,792
| -31% | -$237K | ﹤0.01% | 1318 |
|
|
2021
Q2 | $600K | Sell |
21,863
-1,228
| -5% | -$33.7K | 0.01% | 1232 |
|
|
2021
Q1 | $648K | Buy |
23,091
+2,416
| +12% | +$67.8K | 0.01% | 1133 |
|
|
2020
Q4 | $537K | Sell |
20,675
-1,925
| -9% | -$50K | 0.01% | 1124 |
|
|
2020
Q3 | $387K | Buy |
22,600
+6,447
| +40% | +$110K | ﹤0.01% | 1161 |
|
|
2020
Q2 | $400K | Sell |
16,153
-19,862
| -55% | -$492K | 0.01% | 1099 |
|
|
2020
Q1 | $500K | Sell |
36,015
-5,225
| -13% | -$72.5K | 0.01% | 866 |
|
|
2019
Q4 | $417K | Buy |
41,240
+4,893
| +13% | +$49.5K | 0.01% | 1081 |
|
|
2019
Q3 | $331K | Sell |
36,347
-8,599
| -19% | -$78.3K | 0.01% | 1137 |
|
|
2019
Q2 | $357K | Sell |
44,946
-6,464
| -13% | -$51.3K | 0.01% | 1189 |
|
|
2019
Q1 | $642K | Buy |
51,410
+1,712
| +3% | +$21.4K | 0.01% | 890 |
|
|
2018
Q4 | $535K | Sell |
49,698
-1,962
| -4% | -$21.1K | 0.01% | 877 |
|
|
2018
Q3 | $720K | Buy |
51,660
+34,920
| +209% | +$487K | 0.01% | 814 |
|
|
2018
Q2 | $205K | Buy |
+16,740
| New | +$205K | ﹤0.01% | 1267 |
|